Day 3 - Endo1 Glucose Metabolism Flashcards
NOT high-yield for step 2: Anti-islet antibodies seen in pts w/ diabetes
Review after step 2: anti-isulin, anti-islet cell cytoplasm, anti-glutamic acid decarboxylase, anti-tyrosine phosphatase
Distinguish somygi effect from dawn phenonmenon
Both cause high glucose levels upon waking in the AM; Somogyi effect - glucose too low in middle of night (e.g., evening NPH dose too high), stress hormone (e.g., catecholamines) aka counterregulatory hormones - boost glucose, Tx - decrease evening NPH, NPH at bedtime instead of dinner, snack before bedtime; Dawn phenomenon - because not take enough NPH, glucose never got low, Tx - increase evening NPH; Distinguish w/ 3 AM blood glucose check
DM agents - lactic acidosis as rare but worrisome side effect
Metformin
DM agents - most common side effect hypoglycemia
Sulfonylureas (also meglitinides)
DM agents - oldest and cheapest
Sulfonylureas
DM agents - often used in combo w/ any of other agents
Metformin (often 1st line)
DM agents - also help lower LDL and TG
Metformin
DM agents - Contraindicated in CHF
Thiazolidinediones (pioglitazone, rosiglitazone)
DM agents - not used in pts w/ elevated serum Cr
Metformin; Sulfonylureas
DM agents - not used in patients in IBD
Alpha-glucosidase inhibitors (acarbose); Note: mechanism to decrease GI absorption of starch & dissacharides
DM agents - hepatic serum transaminase levels must be carefully monitored
Metformin (also Thiazolidinediones - pioglitazone, rosiglitazone)
DM agents - not cause weight gain
Metformin
DM agents - metabolized by liver, excellent choice in patients with renal disease
Glitazones
DM agents - Primary affects postprandial glucose & taken w/ meals
Alpha-glucosidase inhibitors (acarbose)
DM agents - 3 newer drugs
(1) Exenatide (2) Sitagliptin (3) Pramlintide (see p. 113 in text) - Review details after step 2